Acute Erythroleukemia
-
Dec 06, 2016 www.marketwired.com
ORYZON Announces Encouraging Top-line Results from Phase I-IIA Clinical Trial in Acute Leukemia of RG6016 (ORY-1001) at the American Society of Hematology 2016 Annual Meeting – Marketwired
Read More